Definium Therapeutics, Inc. - DFTX
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jun 26, 2026 | Chief Legal Officer | S | D | 13,008.0 | 45.03 | 585,750.24 | 320,571.0 | View | |
| Jun 26, 2026 | Chief Financial Officer | S | D | 3,013.0 | 45.03 | 135,675.39 | 209,487.0 | View | |
| Jun 26, 2026 | Chief Executive Officer | S | D | 29,208.0 | 45.03 | 1,315,236.24 | 1,098,246.0 | View | |
| Jun 26, 2026 | Chief Medical Officer | S | D | 10,035.0 | 45.03 | 451,876.05 | 503,282.0 | View | |
| Jun 26, 2026 | Chief Commercial Officer | S | D | 2,867.0 | 45.03 | 129,101.01 | 174,633.0 | View | |
| Jun 22, 2026 | Chief Executive Officer | A | A | 375,000.0 | 0.0 | 0.0 | 1,127,454.0 | View | |
| Jun 22, 2026 | Chief Commercial Officer | A | A | 62,500.0 | 0.0 | 0.0 | 177,500.0 | View | |
| Jun 22, 2026 | Chief Financial Officer | A | A | 62,500.0 | 0.0 | 0.0 | 212,500.0 | View | |
| Jun 22, 2026 | Chief Legal Officer | A | A | 62,500.0 | 0.0 | 0.0 | 333,579.0 | View | |
| Jun 22, 2026 | Chief Medical Officer | A | A | 100,000.0 | 0.0 | 0.0 | 513,317.0 | View | |
| Jun 15, 2026 | — | A | A | 19,188.0 | 0.0 | 0.0 | 19,188.0 | View | |
| Jun 15, 2026 | — | A | A | 4,666.0 | 0.0 | 0.0 | 24,289.0 | View | |
| Jun 15, 2026 | — | A | A | 19,188.0 | 0.0 | 0.0 | 19,188.0 | View | |
| Jun 15, 2026 | — | A | A | 4,666.0 | 0.0 | 0.0 | 19,900.0 | View | |
| Jun 15, 2026 | — | A | A | 19,188.0 | 0.0 | 0.0 | 19,188.0 | View | |
| Jun 15, 2026 | — | A | A | 4,666.0 | 0.0 | 0.0 | 21,210.0 | View | |
| Jun 15, 2026 | — | A | A | 19,188.0 | 0.0 | 0.0 | 19,188.0 | View | |
| Jun 15, 2026 | — | A | A | 4,666.0 | 0.0 | 0.0 | 19,773.0 | View | |
| Jun 15, 2026 | — | A | A | 14,620.0 | 0.0 | 0.0 | 14,620.0 | View | |
| Jun 15, 2026 | — | A | A | 3,555.0 | 0.0 | 0.0 | 3,555.0 | View | |
| Jun 15, 2026 | — | A | A | 19,188.0 | 0.0 | 0.0 | 19,188.0 | View | |
| Jun 15, 2026 | — | A | A | 4,666.0 | 0.0 | 0.0 | 24,289.0 | View | |
| Mar 26, 2026 | Chief Legal Officer | S | D | 10,702.0 | 18.47 | 197,665.94 | 271,079.0 | View | |
| Mar 26, 2026 | Chief Medical Officer | S | D | 8,018.0 | 18.47 | 148,092.46 | 413,317.0 | View | |
| Mar 26, 2026 | Chief Executive Officer | S | D | 24,431.0 | 18.47 | 451,240.57 | 752,454.0 | View | |
| Feb 05, 2026 | Chief Legal Officer | A | A | 125,000.0 | 0.0 | 0.0 | 407,576.0 | View | |
| Feb 05, 2026 | Chief Medical Officer | A | A | 150,000.0 | 0.0 | 0.0 | 575,025.0 | View | |
| Feb 05, 2026 | Chief Executive Officer | A | A | 320,000.0 | 0.0 | 0.0 | 1,098,477.0 | View | |
| Feb 05, 2026 | Chief Financial Officer | A | A | 150,000.0 | 0.0 | 0.0 | 150,000.0 | View | |
| Feb 05, 2026 | Chief Commercial Officer | A | A | 115,000.0 | 0.0 | 0.0 | 115,000.0 | View | |
| Jan 29, 2026 | — | A | A | 50,000.0 | 0.0 | 0.0 | 50,000.0 | View |